PCOS Gets a New Name
PCOS Gets a New Name.
Here's What PMOS Means for You.
After nearly a decade of global research and 22,000 voices, medicine finally has a name that matches the condition.
If you've ever been diagnosed with PCOS — or suspected you might have it — this week's news belongs to you. After nearly a decade of deliberation, a landmark global consensus has renamed polycystic ovarian syndrome to polyendocrine metabolic ovarian syndrome, or PMOS. And the change is more than cosmetic.
The renaming was announced on May 12, 2026, at the European Congress of Endocrinology in Prague and published simultaneously in The Lancet. More than 56 patient and professional organizations participated — including the Endocrine Society — along with 22,000 survey respondents over 11 years. This was not a quiet academic reshuffling. It was a global reckoning.
So what's actually changing, and why does it matter?
The Problem
Why "Polycystic Ovary Syndrome" Was Always Wrong
The old name created two enduring myths that harmed patients for decades.
First: there are no cysts. The so-called "cysts" seen on ultrasound are small follicles — not pathological cysts at all. This misnomer led countless women to be told they looked "normal" on imaging and sent home without answers.
Second: the ovaries are not the main event. PCOS is not primarily a gynecological disorder. It is a complex, multisystem syndrome with hormonal, metabolic, psychological, and dermatological dimensions — and naming it after a single anatomic finding obscured all of that.
For too long, the name reduced a complex, long-term hormonal disorder to a misunderstanding about cysts and a focus on ovaries. This contributed to missed diagnoses and inadequate treatment.
The result: delayed diagnoses, dismissive care, and patients left managing serious metabolic and psychological conditions without a framework that explained what was happening to their bodies.
Breaking Down the New Name
What PMOS Actually Tells Us
This is a condition involving multiple endocrine systems — insulin, androgens, and neuroendocrine hormones. It is a whole-body hormonal disorder, not a single-gland problem.
PMOS has wide-ranging metabolic effects: insulin resistance, obesity, elevated cardiovascular risk, and significantly increased likelihood of developing type 2 diabetes.
The ovaries are genuinely involved and often dysfunctional — causing ovulatory disturbances, irregular cycles, and fertility challenges — but they are one piece of a much larger picture.
Diagnosis
How Is PMOS Diagnosed?
PMOS is a diagnosis of exclusion — meaning other causes of the same symptoms must first be ruled out. Once that's done, diagnosis in adults (over age 20) requires at least two of the following three criteria:
- Oligo-anovulation — infrequent or absent ovulation
- Clinical or biochemical hyperandrogenism — elevated androgens, or symptoms like acne, hair thinning, or excess hair growth
- Polycystic ovaries on ultrasound, or elevated anti-Müllerian hormone (AMH)
In adolescents (ages 10–19), both criteria 1 and 2 must be present for diagnosis.
Clinical Picture
What Does PMOS Look Like?
PMOS affects more than 10% of the female population globally. Its features span nearly every system of the body:
- Obesity
- Blood sugar dysregulation
- Diabetes
- High blood pressure
- Dyslipidemia
- Metabolic liver disease (MASLD)
- Cardiovascular disease
- Sleep apnea
- Irregular menstrual cycles
- Ovulatory dysfunction
- Infertility
- Pregnancy complications
- Elevated endometrial cancer risk
- Depression
- Anxiety
- Eating disorders
- Decreased quality of life
- Acne
- Hair thinning (alopecia)
- Excess hair growth (hirsutism)
If any of this sounds familiar — and you've struggled to get answers — the fragmentation you experienced was a direct consequence of a name that didn't capture the full picture. That is changing now.
Why It Matters
The Goals Behind the Rename
The old name carried heavy associations with weight and fertility. A more accurate name demands more dignified, comprehensive care.
Many providers are still under-informed about this condition. New nomenclature reshapes how it is taught, coded, and treated.
On average, women with this condition wait years for a diagnosis. A name that reflects reality makes it harder to miss.
As one of the patient advocates involved in the process put it: this shift will reframe the conversation and demand that the condition is taken as seriously as the long-term, complex health issue it truly is.
Language matters in medicine. The name we give a condition shapes how we study it, how we treat it, and how patients understand themselves. After decades of living under a name that didn't fit, women with PMOS finally have one that does.
Have Questions About PMOS?
Whether you've been previously diagnosed with PCOS or are wondering if your symptoms might fit, I'd love to talk. I'm here to help you make sense of it all.
Book a Consultation